NEW YORK (GenomeWeb News) — The Wistar Institute and the University of the Sciences, both located in Philadelphia, today unveiled a new Molecular Screening Facility at the institute, which is part of a larger medical research partnership between them that will seek new compounds for potential therapies.

 

The $1.1 million screening facility and the Center for Chemical Biology and Translational Medicine combines Wistar’s biomedical research capabilities with the University of Sciences’ chemical and pharmacological expertise.